23.90Open23.90Pre Close0 Volume14 Open Interest55.00Strike Price0.00Turnover6400.13%IV2.22%PremiumDec 13, 2024Expiry Date22.19Intrinsic Value100Multiplier-1DDays to Expiry1.71Extrinsic Value100Contract SizeAmericanOptions Type0.9982Delta0.0006Gamma3.50Leverage Ratio-17.5732Theta0.0000Rho3.49Eff Leverage0.0000Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet